Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance resultsNorio Hanafusa, Michio Kato, Tomoaki Ishihara et al.|PLoS ONE|2017Cited by 56